Works matching IS 10584838 AND DT 2012 AND VI 55 AND IP suppl_2

Results: 16

Current State of Clostridium difficile Treatment Options.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S71, doi. 10.1093/cid/cis355

By:

Venugopal, Anilrudh A.;
Johnson, Stuart

Publication type:

Article

Current Status of Clostridium difficile Infection Epidemiology.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S65, doi. 10.1093/cid/cis319

By:

Lessa, Fernanda C.;
Gould, Carolyn V.;
McDonald, L. Clifford

Publication type:

Article

Burden of Clostridium difficile on the Healthcare System.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S88, doi. 10.1093/cid/cis335

By:

Dubberke, Erik R.;
Olsen, Margaret A.

Publication type:

Article

Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S121, doi. 10.1093/cid/cis440

By:

Nerandzic, Michelle M.;
Mullane, Kathleen;
Miller, Mark A.;
Babakhani, Farah;
Donskey, Curtis J.

Publication type:

Article

Fidaxomicin Inhibits Spore Production in Clostridium difficile.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S162, doi. 10.1093/cid/cis453

By:

Babakhani, Farah;
Bouillaut, Laurent;
Gomez, Abraham;
Sears, Pamela;
Nguyen, Ly;
Sonenshein, Abraham L.

Publication type:

Article

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S77

By:

Eyre, David W.;
Walker, A. Sarah;
Wyllie, David;
Dingle, Kate E.;
Griffiths, David;
Finney, John;
O'Connor, Lily;
Vaughan, Alison;
Crook, Derrick W.;
Wilcox, Mark H.;
Peto, Timothy E. A.

Publication type:

Article

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S149, doi. 10.1093/cid/cis340

By:

Bauer, Martijn P.;
Hensgens, Marjolein P. M.;
Miller, Mark A.;
Gerding, Dale N.;
Wilcox, Mark H.;
Dale, Adam P.;
Fawley, Warren N.;
Kuijper, Ed J.;
Gorbach, Sherwood L.

Publication type:

Article

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S104, doi. 10.1093/cid/cis357

By:

Figueroa, Iris;
Johnson, Stuart;
Sambol, Susan P.;
Goldstein, Ellie J. C.;
Citron, Diane M.;
Gerding, Dale N.

Publication type:

Article

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S132, doi. 10.1093/cid/cis338

By:

Louie, Thomas J.;
Cannon, Kris;
Byrne, Brendan;
Emery, Judy;
Ward, Linda;
Eyben, Melissa;
Krulicki, Walter

Publication type:

Article

Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S110, doi. 10.1093/cid/cis390

By:

Weiss, Karl;
Allgren, Robin L.;
Sellers, Sarah

Publication type:

Article

Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S127, doi. 10.1093/cid/cis358

By:

Artsimovitch, Irina;
Seddon, Jaime;
Sears, Pamela

Publication type:

Article

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S154, doi. 10.1093/cid/cis462

By:

Cornely, Oliver A.;
Miller, Mark A.;
Louie, Thomas J.;
Crook, Derrick W.;
Gorbach, Sherwood L.

Publication type:

Article

Clinical Infectious Diseases.

Published in:: 2012
Publication type:: Film/TV Criticism and Review

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S93, doi. 10.1093/cid/cis499

By:

Crook, Derrick W.;
Walker, A. Sarah;
Kean, Yin;
Weiss, Karl;
Cornely, Oliver A.;
Miller, Mark A.;
Esposito, Roberto;
Louie, Thomas J.;
Stoesser, Nicole E.;
Young, Bernadette C.;
Angus, Brian J.;
Gorbach, Sherwood L.;
Peto, Timothy E. A.

Publication type:

Article

Antimicrobial Activities of Fidaxomicin.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S143, doi. 10.1093/cid/cis339

By:

Goldstein, Ellie J. C.;
Babakhani, Farah;
Citron, Diane M.

Publication type:

Article

Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection.

Published in:

Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S116, doi. 10.1093/cid/cis337

By:

Sears, Pamela;
Crook, Derrick W.;
Louie, Thomas J.;
Miller, Mark A.;
Weiss, Karl

Publication type:

Article